Trials / Active Not Recruiting
Active Not RecruitingNCT07045883
Mechanism and Application of Vitamin D in Idiopathic Sudden Sensorineural Hearing Loss
Mechanism and Clinical Application of Vitamin D in Influencing the Prognosis of Idiopathic Sudden Sensorineural Hearing Loss
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 197 (estimated)
- Sponsor
- Zhongshan Hospital Xiamen University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Clinical Trial Protocol: Investigating the Therapeutic Efficacy of Vitamin D in ISSNHL。Core Research Questions Can vitamin D supplementation improve the prognosis of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)? What potential medical issues might arise during vitamin D administration? Study Design A controlled trial comparing: Intervention group: Vitamin D supplementation + standard care Control group: Standard care alone Participant Procedures Baseline assessment: Venous blood draw (2 mL) for 25(OH)D level measurement. intervention phase:Daily vitamin D supplementation for 1 month Endpoint evaluation (1-month follow-up): Repeat audiometric testing (pure-tone audiometry). Post-treatment 25(OH)D concentration analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin D Supplementation+ standard treatment | The experimental group was tested for 25(OH)D concentration after enrollment, and the experimental group was divided into vitamin D deficiency group and vitamin D normal group. In the vitamin D-deficient group, participants will receive standard treatment plus oral vitamin D3 supplementation (800 IU daily for 4 weeks), whereas the vitamin D normal group will receive standard treatment alone |
| OTHER | standard treatment | The experimental group was tested for 25(OH)D concentration after enrollment, and the experimental group was divided into vitamin D deficiency group and vitamin D normal group. The vitamin D normal group will receive standard treatment alone |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2025-07-01
- Last updated
- 2025-07-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07045883. Inclusion in this directory is not an endorsement.